Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS

Status:
Not yet recruiting

Trial end date:
2025-02-28

Target enrollment:

Participant gender:

This study will assess the effects and safety of PTC857 treatment in participants diagnosed with ALS.

Phase 2

PTC Therapeutics